• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹腔穿刺术与利尿剂治疗肝硬化腹水患者的疗效比较

Paracentesis versus diuretics in the treatment of cirrhotics with tense ascites.

作者信息

Quintero E, Ginés P, Arroyo V, Rimola A, Bory F, Planas R, Viver J, Cabrera J, Rodés J

出版信息

Lancet. 1985 Mar 16;1(8429):611-2. doi: 10.1016/s0140-6736(85)92147-6.

DOI:10.1016/s0140-6736(85)92147-6
PMID:2857949
Abstract

72 cirrhotics with tense ascites were randomly assigned to treatment with either paracentesis plus intravenous albumin infusion (38 patients) or diuretics (34 patients). Paracentesis was not associated with significant changes in renal function. The clinical course of the disease was similar in the two groups of patients, both during their hospital stay and during follow-up.

摘要

72例伴有张力性腹水的肝硬化患者被随机分为两组,分别接受腹腔穿刺放液联合静脉输注白蛋白治疗(38例患者)或利尿剂治疗(34例患者)。腹腔穿刺放液与肾功能的显著变化无关。两组患者在住院期间及随访期间的疾病临床进程相似。

相似文献

1
Paracentesis versus diuretics in the treatment of cirrhotics with tense ascites.腹腔穿刺术与利尿剂治疗肝硬化腹水患者的疗效比较
Lancet. 1985 Mar 16;1(8429):611-2. doi: 10.1016/s0140-6736(85)92147-6.
2
Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study.腹腔穿刺术与利尿剂治疗肝硬化腹水患者的比较:一项随机研究的结果
Gastroenterology. 1987 Aug;93(2):234-41. doi: 10.1016/0016-5085(87)91007-9.
3
Therapeutic effects of diuretics and paracentesis on lung function in patients with non-alcoholic cirrhosis and tense ascites.利尿剂和腹腔穿刺术对非酒精性肝硬化合并张力性腹水患者肺功能的治疗效果。
J Hepatol. 1997 Apr;26(4):833-8. doi: 10.1016/s0168-8278(97)80249-8.
4
Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo.非氮质血症肝硬化患者治疗性腹腔穿刺放液后的利尿剂需求。螺内酯与安慰剂的随机双盲试验。
J Hepatol. 1997 Mar;26(3):614-20. doi: 10.1016/s0168-8278(97)80427-8.
5
Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.肝硬化腹水的治疗。利尿剂、腹腔静脉分流术及大量腹腔穿刺放液术。
Gastroenterol Clin North Am. 1992 Mar;21(1):237-56.
6
Repeated paracentesis and i.v. albumin infusion to treat 'tense' ascites in cirrhotic patients. A safe alternative therapy.反复腹腔穿刺放液及静脉输注白蛋白治疗肝硬化患者的“紧张性”腹水。一种安全的替代疗法。
J Hepatol. 1987 Aug;5(1):102-8. doi: 10.1016/s0168-8278(87)80067-3.
7
Comparative pilot study of repeated large volume paracentesis vs the combination on clonidine-spironolactone in the treatment of cirrhosis-associated refractory ascites.重复大量腹腔穿刺术与可乐定-螺内酯联合治疗肝硬化相关性难治性腹水的对比性初步研究
Gastroenterol Clin Biol. 2005 Nov;29(11):1137-42. doi: 10.1016/s0399-8320(05)82178-5.
8
Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study.右旋糖酐70与白蛋白作为肝硬化大量腹水患者经完全腹腔穿刺放液治疗时的血浆扩容剂。一项随机研究的结果
Gastroenterology. 1990 Dec;99(6):1736-44. doi: 10.1016/0016-5085(90)90481-f.
9
Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.肝硬化患者治疗性腹腔穿刺放液联合与不联合静脉输注白蛋白的随机对照研究
Gastroenterology. 1988 Jun;94(6):1493-502. doi: 10.1016/0016-5085(88)90691-9.
10
Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study.
J Hepatol. 1994 Feb;20(2):282-8. doi: 10.1016/s0168-8278(05)80070-4.

引用本文的文献

1
Use of albumin infusion for cirrhosis-related complications: An international position statement.白蛋白输注在肝硬化相关并发症中的应用:一项国际立场声明。
JHEP Rep. 2023 May 5;5(8):100785. doi: 10.1016/j.jhepr.2023.100785. eCollection 2023 Aug.
2
A History of the Assessment of Liver Performance.肝脏功能评估的历史
Clin Liver Dis (Hoboken). 2021 Oct 29;18(Suppl 1):28-48. doi: 10.1002/cld.1100. eCollection 2021 Oct.
3
Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.失代偿期肝硬化成人腹水的治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 16;1(1):CD013123. doi: 10.1002/14651858.CD013123.pub2.
4
Current management of refractory ascites in patients with cirrhosis.肝硬化患者难治性腹水的当前管理。
J Int Med Res. 2018 Mar;46(3):1138-1145. doi: 10.1177/0300060517735231. Epub 2017 Dec 6.
5
Computerized Tomography-Guided Paracentesis: An Effective Alternative to Bedside Paracentesis?计算机断层扫描引导下的腹腔穿刺术:床边腹腔穿刺术的有效替代方法?
J Clin Med Res. 2017 Feb;9(2):92-97. doi: 10.14740/jocmr2832w. Epub 2016 Dec 31.
6
Management of refractory ascites in cirrhosis: Are we out of date?肝硬化难治性腹水的管理:我们过时了吗?
World J Hepatol. 2016 Oct 8;8(28):1182-1193. doi: 10.4254/wjh.v8.i28.1182.
7
Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives: Chapter 5 Human Albumin - Revised.血液成分及血浆衍生物治疗的横断面指南:第5章 人血白蛋白 - 修订版
Transfus Med Hemother. 2016 May;43(3):223-32. doi: 10.1159/000446043. Epub 2016 May 3.
8
Management of cirrhotic ascites.肝硬化腹水的管理
Ther Adv Chronic Dis. 2015 May;6(3):124-37. doi: 10.1177/2040622315580069.
9
Effects of paracentesis on hemodynamic parameters and respiratory function in critically ill patients.腹腔穿刺术对危重症患者血流动力学参数及呼吸功能的影响。
BMC Gastroenterol. 2014 Jan 27;14:18. doi: 10.1186/1471-230X-14-18.
10
Malignant ascites: pathophysiology and treatment.恶性腹水:病理生理学与治疗。
Int J Clin Oncol. 2013 Feb;18(1):1-9. doi: 10.1007/s10147-012-0396-6. Epub 2012 Mar 31.